#$%^&*AU2020203146A120200618.pdf#####Abstract The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising coadministering a therapeutically effective amount of a first compound, and a therapeutically effective amount of a second compound. In certain embodiments, the first compound or the second compound inhibits AB peptide polymerization； is an anti-inflammatory； improves cognitive function, mood, or social behaviour； is associated with Tau or alpha-synuclein； or regulates amyloid peptide washout.WO 2014/066318 PCT/US2013/066069 .. ...... ...... m mwN.... .N .. . . . . ... . .. . . m 4V ~''~ Nm ..... ..... . ... ... ... .. F' i SU SITT SHE (R LE26
